Abeona Therapeutics Inc vs Williams Companies Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Williams Companies Inc trades at $71.97 (market cap $88.45B). The key difference: Williams Companies Inc is far larger — about 210× Abeona Therapeutics Inc's market cap, and Williams Companies Inc pays a 2.9% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | WMB | |
|---|---|---|
Market Cap | $421.19M | $88.45B |
Sector | Health | Energy |
52-Week High | $7.45 | $79.40 |
52-Week Low | $4.17 | $56.51 |
Enterprise Value | $276.10M | $119.07B |
Dividend Yield | — | 2.9% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →